Search

Displaying results 3691 - 3700 of 10000 in total
  1. Pathway

    Acylcarnitine 5-Hydroxydec-3-enedioylcarnitine

    smpdb.ca/view/SMP0123885
    Metabolic

    5-Hydroxydec-3-enedioylcarnitine is an acylcarnitine. … In forming an acylcarnitine derivative, 5-hydroxydec-3-enedioyl-CoA reacts with L-carnitine to form 5-hydroxydec-3-enedioylcarnitine. This reaction is catalyzed by carnitine O-palmitoyltransferase.

    Drugs: Biotin · Adenosine phosphate · ATP · Levocarnitine · Magnesium cation · Pyrophosphoric acid +1 more
    Enzymes: Solute carrier family 22 member 5
  2. Pathway

    Acylcarnitine (5E)-Undec-5-enoylcarnitine

    smpdb.ca/view/SMP0123950
    Metabolic

    (5E)-Undec-5-enoylcarnitine is an acylcarnitine. … In forming an acylcarnitine derivative, (5E)-undec-5-enoyl-CoA reacts with L-carnitine to form (5E)-undec-5-enoylcarnitine. This reaction is catalyzed by carnitine O-palmitoyltransferase.

    Drugs: Biotin · Adenosine phosphate · ATP · Levocarnitine · Magnesium cation · Pyrophosphoric acid +1 more
    Enzymes: Solute carrier family 22 member 5
  3. Pathway

    Acylcarnitine 3-Hydroxydodec-5-enedioylcarnitine

    smpdb.ca/view/SMP0124025
    Metabolic

    3-Hydroxydodec-5-enedioylcarnitine is an acylcarnitine. … In forming an acylcarnitine derivative, 3-hydroxydodec-5-enedioyl-CoA reacts with L-carnitine to form 3-hydroxydodec-5-enedioylcarnitine.

    Drugs: Biotin · Adenosine phosphate · ATP · Levocarnitine · Magnesium cation · Pyrophosphoric acid +1 more
    Enzymes: Solute carrier family 22 member 5
  4. Pathway

    Acylcarnitine 5-Hydroxytrideca-7,9-dienoylcarnitine

    smpdb.ca/view/SMP0124120
    Metabolic

    5-Hydroxytrideca-7,9-dienoylcarnitine is an acylcarnitine. … In forming an acylcarnitine derivative, 5-hydroxytrideca-7,9-dienoyl-CoA reacts with L-carnitine to form 5-hydroxytrideca-7,9-dienoylcarnitine.

    Drugs: Biotin · Adenosine phosphate · ATP · Levocarnitine · Magnesium cation · Pyrophosphoric acid +1 more
    Enzymes: Solute carrier family 22 member 5
  5. Pathway

    Acylcarnitine (5E)-Tetradec-5-enedioylcarnitine

    smpdb.ca/view/SMP0124161
    Metabolic

    (5E)-Tetradec-5-enedioylcarnitine is an acylcarnitine. … In forming an acylcarnitine derivative, (5E)-tetradec-5-enedioyl-CoA reacts with L-carnitine to form (5E)-tetradec-5-enedioylcarnitine. This reaction is catalyzed by carnitine O-palmitoyltransferase.

    Drugs: Biotin · Adenosine phosphate · ATP · Levocarnitine · Magnesium cation · Pyrophosphoric acid +1 more
    Enzymes: Solute carrier family 22 member 5
  6. Pathway

    Acylcarnitine (5Z)-Pentadec-5-enoylcarnitine

    smpdb.ca/view/SMP0124233
    Metabolic

    (5Z)-Pentadec-5-enoylcarnitine is an acylcarnitine. … In forming an acylcarnitine derivative, (5Z)-pentadec-5-enoyl-CoA reacts with L-carnitine to form (5Z)-pentadec-5-enoylcarnitine. This reaction is catalyzed by carnitine O-palmitoyltransferase.

    Drugs: Biotin · Adenosine phosphate · ATP · Levocarnitine · Magnesium cation · Pyrophosphoric acid +1 more
    Enzymes: Solute carrier family 22 member 5
  7. Drug

    Tolvaptan

    go.drugbank.com/drugs/DB06212
    ApprovedInvestigational

    FDA approved on May 19, 2009.

    Categories: P-glycoprotein substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic IndexProducts: JİNARC 15 MG TABLET, 56 ADET, Jidren 15 mg Tablet, 56 ADET
  8. Drug

    Brompheniramine

    go.drugbank.com/drugs/DB00835
    Approved

    Histamine H1 antagonist used in treatment of allergies, rhinitis, and urticaria.

    Mixtures: M-end Wc, M-end PECategories: Cytochrome P-450 Substrates, Heterocyclic Compounds, 1-Ring
  9. Drug

    Sulfacetamide

    go.drugbank.com/drugs/DB00634
    Approved

    An anti-infective agent that is used topically to treat skin infections and orally for urinary tract infections.

    Mixtures: BRUMETON 1 MG/ML+100 MG/ML GÖZ DAMLASI, SUPRENIL STERIL OFTALMIK SUSPANSIYON 5 MLSynonyms: N(1)-Acetylsulfanilamide, N(1)-Acetyl-4-aminophenylsulfonamide
  10. Drug

    Roxadustat

    go.drugbank.com/drugs/DB04847
    ApprovedInvestigational

    Roxadustat is a first-in-class hypoxia-inducible factor prolyl hydroxylase inhibitor used to treat anemia associated with chronic kidney disease. … It works by reducing the breakdown of the hypoxia-inducible factor (HIF), which is a transcription factor that stimulates red blood cell production in response to low oxygen levels.

    Categories: Cytochrome P-450 Substrates, Heterocyclic Compounds, 2-RingProducts: Ernevod 50 mg Film Kaplı Tablet (12 adet), EVRENZO 50 MG FİLM KAPLI TABLET, 12 ADET